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RESUmEn
Objetivo: Evaluar la contribución de la 
auriculoterapia al cese del tabaquismo. 
Método: Ensayo clínico aleatorizado, con-
trolado y doble ciego conducido con 30 ta-
baquistas dispuestos en dos grupos: Grupo 
Experimental (21 participantes recibieron 
10 sesiones de auriculoterapia en puntos 
específicos para el tabaquismo) y Grupo 
Control (nueve participantes recibieron 
auriculoterapia en puntos que no tienen 
efecto sobre el foco de investigación). 
Resultados: El tratamiento con auriculo-
terapia contribuyó para la reducción de la 
cantidad de cigarrillos fumados en el 61,9% 
de los participantes (p=0,002), la reducción 
de la dificultad de permanecer sin fumar 
en sitios prohibidos en el 38% (p=0,050) y 
en no fumar cuando enfermos en el 23,8% 
(p=0,025). Conclusión: Ante la efectividad 
solo en términos de reducción de la canti-
dad de cigarrillos consumidos y los demás 
parámetros evaluados, se sugiere que tra-
bajos futuros consideren la utilización de la 
auriculoterapia asociada con otros méto-
dos de tratamiento, a fin de alcanzar mejo-
res resultados de cese/abstinencia.
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RESUmo
Objetivo: Avaliar a contribuição da auri-
culoterapia na cessação do tabagismo. 
Método: Ensaio clínico controlado, ran-
domizado e duplo cego conduzido com 30 
tabagistas alocados em dois grupos: Grupo 
Experimental (21 participantes receberam 
10 sessões de auriculoterapia em pontos 
específicos para o tabagismo) e Grupo 
Controle (nove participantes receberam a 
auriculoterapia em pontos que não pos-
suem efeito sobre o foco de investigação). 
Resultados: O tratamento com auriculo-
terapia contribuiu na redução do número 
de cigarros fumados em 61,9% dos partici-
pantes (p=0,002), na redução da dificulda-
de de ficar sem fumar em locais proibidos 
em 38% (p=0,050) e em não fumar quando 
doente em 23,8% (p=0,025). Conclusão: 
Diante da eficácia apenas em termos de 
redução do número de cigarros consumi-
dos e dos demais parâmetros avaliados, 
sugere-se que trabalhos futuros conside-
rem a utilização da auriculoterapia associa-
da a outros métodos de tratamento, com 
intuito de alcançar melhores resultados de 
cessação/abstinência.
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AbStRACt
Objective: To evaluate the contribution 
of auriculotherapy in smoking cessation. 
Method: Double-blind randomized con-
trolled trial, conducted with 30 smokers 
allocated into two groups: Experimental 
Group (21 participants received 10 ses-
sions of auriculotherapy at specific points 
for smoking) and Control Group (nine 
participants received auriculotherapy in 
points that have no effect on the focus 
of research). Results: Auriculotherapy 
contributed in reducing the number of 
cigarettes smoked in 61.9% of partici-
pants (p=0.002), in reducing the difficult 
to abstain from smoking in places where 
it is forbidden by 38% (p=0.050) and in 
not smoking when ill 23.8% (p=0.025). 
Conclusion: Given the efficacy only in 
terms of reducing the number of cigarettes 
smoked and other parameters, we suggest 
that future studies consider the use of au-
riculotherapy combined with other treat-
ment methods, in order to achieve better 
results in cessation/abstinence.
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intRodUCtion
The World Health Organization (WHO) estimates that 
in the twenty-first century, nearly one billion people will 
die from diseases caused by tobacco use(1). Such use is 
characterized as health threat behavior, being considered a 
public health problem, since it is the second leading cause 
of morbidity and mortality in the world(2). Furthermore, to-
bacco use and the burden of diseases associated with its 
use are growing, particularly in developing countries(2).
In Brazil, the number of deaths occurred as conse-
quences of smoking are higher than caused by alcoholism, 
AIDS, traffic accidents, homicides and suicides, reaching a 
rate of 200,000 deaths per year(3). According to the Sec-
ond National Survey of Alcohol and Drugs (LENAD) con-
ducted in 2013, in 149 municipalities, involving 4,607 indi-
viduals of 14 years or more, found a prevalence of 19.3% 
of tobacco users. Considering national representativeness 
of the sample, one can estimate that there are, in Brazil, 
around 20 million smokers(4).
The hazardous effects of smoking were shown to be 
associated with more than 50 types of diseases, not re-
stricted to the respiratory system. Six of the eight lead-
ing causes of death have as a risk factor smoking, linked 
to several types of cancers (lung, larynx, kidney, blad-
der, stomach, cervix, oral cavity, esophagus), respiratory 
diseases (chronic bronchitis, Chronic Obstructive Pul-
monary Disease - COPD), heart (ischemic heart disease, 
acute myocardial infarction), and abortion, infertility, 
male erectile dysfunction, reduced insulin sensitivity, in-
creased propensity to psychiatric disorders, among other 
health problems(5).
Given the intense problem that smoking involves, 
since the 1980s the Brazilian Ministry of Health is invest-
ing in the creation of laws, ordinances, decrees and reso-
lutions to contain the spread of smoking in the country. 
Treatment of smoking cessation is offered by the Unified 
Health System (SUS), through various approaches (nico-
tine replacement therapy and motivational interventions) 
that are offered at all levels of complexity of health care(6).
The current trend is to replace the models of care fo-
cused on illness, healing and drug intervention, by prac-
tices that promote the integrality of health care and in-
volving preventive interventions, health promotion and 
the search for improved quality of life, such as integrative 
person-centered practices. Complementary therapies 
such as auriculotherapy, acupuncture and electrical stim-
ulation have received little attention in research, although 
they are widely used in clinical practice, including for be-
ing considered safe and effective interventions in smok-
ing cessation. Among the available therapies, we highlight 
auriculotherapy or ear acupuncture, a procedure of Tradi-
tional Chinese Medicine (TCM) focusing in the control and 
treatment of many diseases through stimulation of ear 
acupuncture points(7).
When performing a peripheral stimulus on the network 
of blood and nerve flow, it generates an action potential, 
which transmits the nerve impulse to the thalamus and 
then cerebellum, brainstem, brain and all brain nuclei. 
Thus, sensitivity of auricular points triggers a series of bio-
chemical phenomena related to each area of the body, 
thus getting streamlining of the energy balance process(7).
In recent years, researchers have contributed to scien-
tific research on a larger scale, in the context of systemic 
acupuncture compared to auriculotherapy. However, the 
evidence on auriculotherapy, which were conducted with 
appropriate methodological rigor, showed similar results 
to systemic technique, both in terms of clinical efficacy 
and the elements of neurophysiology(8).
Specifically for smoking, experimental studies have 
investigated the effects of auriculotherapy as an aid in 
smoking cessation(9-10). However, we highlight that previ-
ous studies have had significant methodological limita-
tions, including small sample sizes, lack of randomization, 
lack of blinding on the assessments, high dropout rates 
and outcomes that depend only on self-report(11).
A meta-analysis(12) concluded that auriculotherapy 
proved to be effective in smoking cessation, but the ef-
fect may not depend on the location point. A Systematic 
review also showed that there is no evidence free from 
methodological biases that acupuncture, laser therapy or 
electrostimulation are considered effective practices for 
smoking cessation(11).It is worth noting scarcity of invest-
ment in research on the use of auriculotherapy for quali-
fied healthcare professionals to develop this practice. 
Specifically, one may notice a few experimental studies 
evaluating the contribution of auriculotherapy in smoking 
cessation in the Brazilian scenario. Therefore, this study 
aimed to assess the contribution of the use of auriculo-
therapy in smoking cessation.
mEtHod
This is a pilot study planned as double-blind random-
ized controlled trial, with workers from a public university 
in southern Minas Gerais, Brazil. The subjects were select-
ed according to eligibility criteria: age ≥ 18 years; smoking 
at least one cigarette per day; presenting level of exhaled 
carbon monoxide (COex) over six ppm (parts per million); 
expressing the desire to quit smoking; and having the 
availability of time to attend the sessions of auriculother-
apy. Exclusion criteria: presence of infection, inflamma-
tion or injury in the ear; use of piercing in the ear (except 
regular earring); participate in other treatment for smok-
ing cessation (medicated or not); be in gestational period; 
and does not show in two or more consecutive sessions.
When considering the eligibility criteria, the sample 
was initially composed of 35 subjects divided by strati-
fied randomization (the degree of dependence of the 
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initial nicotine) and divided into two groups: Experimental 
Group (24 individuals) and Control Group (11 subjects). In 
the course of implementing the intervention, the initial 
sample of 35 individuals, five were removed as exclusion 
criteria (consecutive no show in two or more sessions). 
Thus, the sample consisted of 30 individuals: Experimen-
tal Group (21 who received auriculotherapy at specific 
points for tobacco control) and Control Group (nine re-
ceiving auriculotherapy in points considered irrelevant to 
tobacco control and that do not cause health risk).
The data collection instrument is composed of three 
parts: 1) demographic information, 2) Fagerstrom Test for 
Nicotine Dependence (FTND), and 3) A Form to monitor 
the intervention. Sociodemographic information refer to 
gender, age, marital status, housing, personal income, 
presence of disease, be undergoing behavioral therapy 
and practice of physical activity.
FTND is a test to measure the level of severity of to-
bacco dependence, developed by Karl-Olov Fagerstrom in 
1978, based on the Fagerstrom Tolerance Questionnaire 
(FTQ)(13). In 1991, after its adaptation, it was renamed to 
Fagerstrom Test for Nicotine Dependence(14).
In Brazil, FTND was translated and validated by Carmo 
and Pueyo(15), who identified an index of internal con-
sistency of 0.642, a similar result to the English (0.61), 
French (0.70), Spain (0.66) and Dutch (0.71) versions. In 
a Brazilian study of test-retest correlation, it was found a 
Cronbach’s alpha of 0.915, close to the French transcul-
tural adaptation 0.85(15), which facilitates its use.
FTND consists of six items, which refer to the diffi-
culty to abstain from smoking in forbidden places and 
when bedridden by illness, the number of cigarettes 
smoked, the time taken after waking up to smoke the first 
cigarette, if the first cigarette in the morning is the one 
which brings more satisfaction and whether the individual 
smokes more in the early morning hours. The response 
items from the first to the sixth questions range from zero 
to three points and the other items, from zero to one. The 
sum of total of points is equal to 10, so the dependence 
is classified as: (0 - 2 points) very low dependence; (3 - 4 
points) low dependence; (5 points) medium dependence; 
(6 - 7 points) high dependence; and (8 - 10 points) very 
high dependence (15).
The form used for monitoring the intervention con-
tains information about the perceived adverse reactions 
during or after the sessions, number of cigarettes smoked 
(NCS) at the beginning and end of the intervention, de-
gree of nicotine dependence (DND) obtained by FTND and 
COex measured at baseline and at the end of the fifth and 
seventh session, at the end of treatment (tenth session) 
and at follow-up (30 days after the last session).
COex was measured by the monoximeter, a device that 
measures the concentration of expired CO by an electro-
chemical sensor, expressing it in parts per million (ppm). 
For this measurement was asked to participants inspire 
their total lung capacity (ambient air) then make an inspi-
ratory pause of 15 seconds, so that the CO in the blood 
could come into equilibrium with the alveolar air, allowing 
the device to estimate, with better accuracy, the concen-
tration of CO in the blood from COex. After this interval, 
participants were instructed to exhale slowly and com-
pletely in the mouthpiece of the device. Values above six 
ppm of COex were considered significant for smoking, as 
evidenced in the literature(16).
COex measurements were standardized to be always 
performed at the same time of the day, in order to mini-
mize the effects of the number of cigarettes smoked on 
the result, ensuring that the interval between the last 
smoked cigarette and COex measurement, as well as the 
number of cigarettes smoked since the last measurement. 
They were similar in all evaluations, considering smoking 
to be related to routine habits.
Application of auriculotherapy
In auriculotherapy, mustard seeds were used. The 
procedure was applied by nursing professionals who 
are specialized in auriculotherapy, with ear acupuncture 
points of the Chinese board(7). Two weekly sessions were 
held for five weeks, totaling 10 sessions, alternating au-
ricles each session.
Before starting the procedure with the placement of the 
mustard seed, the auricle was cleaned with alcohol 70%. 
The seed was stuck in the ear with tape, the participant was 
asked to stimulate the points three times daily. Possible 
discomforts related to pain at the site, and the presence of 
adverse effects were reported to study participants.
Ear points were determined according to the literature, 
for the experimental group were: Shenmen, Kidney, Sympa-
thetic, Anxiety 1, Anxiety 2, Hunger, Thirst and Addictions. 
For the Control Group, the points stimulated, considered 
irrelevant to tobacco control were Elbow and Arm. Two 
points were determined for the Control Group, with a view 
to stimulating a greater number of points, chosen randomly 
without therapeutic purposes, causing energy imbalance 
in the individual(7). Participants were instructed that there 
were other people who were undergoing the procedure, 
but with a different seed number in the ear.
Assessment procedures were performed in session 
zero, called initial assessment (baseline), 5th session, 7th 
session, 10th session (end) and 30 days after completion of 
treatment (follow-up).
It is noteworthy that the blinding of the strategies 
used for data collection was conducted. Thus, the profes-
sional who applied the procedure for placing the seeds 
did not perform assessment procedures. The evaluator 
did not know which group the patient belonged and did 
not know which treatment the patient was receiving ac-
tive or placebo.
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Analysis of results
A database was initially developed in a spreadsheet 
(Microsoft Office Excel 2007) and later in the Statisti-
cal Package for Social Science (SPSS) version 17 for 
Windows. The results were described in tables with 
percentages and absolute frequencies. Chi-square test 
(χ²) was used to verify independence between demo-
graphic, clinical and pattern of tobacco use variables, 
according to the Experimental and Control Groups. In 
situations of expected values smaller than five, Fisher’s 
exact test was used.
To check the adherence of the data distribution to nor-
mality, we used the Shapiro-Wilk test. After this test, to 
determine the association between qualitative and quan-
titative variables, with description of two groups, we used 
the Student t-test by the presence of normality and the 
Mann-Whitney test in the absence of normality. Faced 
with a lack of normal distribution, Wilcoxon test was used 
to evaluate a given variable at different moment. We ad-
opted a significance level of 5% for all tests.
Ethical aspects
In order to ensure the rights of participants and meet 
the aspects contained in Resolution 466/2012 of the 
Brazilian Ministry of Health, the project was approved 
by the Ethics in Research involving Humans (CAAE: 
08777112.9.0000.5142). It was also held the registration 
of study in Brazilian Clinical Trials Registry (Rebec) plat-
form, under approved number RBR-3xktv5.
RESULtS
Sociodemographic information
We observed homogeneity of the sample in all inves-
tigated variables between the Experimental and Control 
Group. The sample was characterized by adults with a 
mean age of 41 years old, female (66.7%), married (70%), 
living with family (96.6%), with income of up to five mini-
mum wagesa (90%), reporting an illness (70%) had no his-
tory of behavioral therapy (86.7%) and non-practicing of 
physical activities (63.3%).
Pattern of tobacco consumption
Tobacco consumption at the beginning and end of 
treatment are presented in Table 1. We observed that, ini-
tially, the groups were homogeneous regarding the con-
sumption of tobacco and at the end of treatment, no sig-
nificant differences were found between the experimental 
and control group.
It is observed in Table 1 that there was a gradual re-
duction of most indicators evaluated throughout the in-
tervention period for both groups. However, the mean are 
clinically lower in the Experimental Group, mainly related 
to the level of COex, for which the level remained un-
changed from the end of treatment for the Control Group, 
unlike the Experimental Group, which showed a mean dif-
ference reduction of 4.11 ppm.
Table 1 – Tobacco use (mean - x¯  and standard deviation - SD) at 
baseline and at the end for the Experimental and Control Group 
– Minas Gerais, 2014
Variables Experimentalx¯  ± dp
Control
x¯  ± dp p-value
Baseline
DND 3,2 ± 1,3 3,9 ± 1,6 0,226
COex 18,4 ± 7,1 16,7 ± 4,3 0,657
NCS 18,2 ± 6,2 17,1 ± 5,6 0,657
End
DND 2,2 ± 1,1 2,7 ± 1,6 0,563
COex 14,3 ± 7,0 16,7 ± 4,4 0,114
NCS 11,2 ± 7,0 11,3 ± 6,0 0,790
Mann-Whitney test; DND: Degree of Nicotine dependence; COex: carbon 
monoxide in exhaled air; NCS: Number of cigarettes smoked.
Table 2 - Number of cigarettes smoked during the study (NCS), 
mean differences between Experimental and Control Group - 
Minas Gerais, 2014
NCS vs Groups Mean difference
Standard 
error p-value
End versus 
baseline
Experimental -7,0 1,4
0,648
Control -5,7 2,5
Follow-up 
versus End
Experimental -0,1 1,3
0,230
Control 2,7 1,8
Student’s t-test.
a The minimum wage in Brazil corresponds to R$ 724,00 reais or U$ 323,27 
dollars according to the Central Bank of Brazil on August 30th, 2014.
Number of cigarettes smoked
As for the NCS throughout the study, we observed 
that there were no statistically significant differences 
between groups. However, it was found that the Ex-
perimental Group had 1.2 times more reduction of NCS 
at the end of treatment, as well as participants in the 
Control Group returned to smoking, on average, three 
cigarettes after a month of the end of the sessions, while 
Experimental Group remained the same at the end of 
treatment (Table 2).
When evaluating the number of cigarettes smoked per 
day (FTND), it was found that, at the end of the five-week 
intervention, 13 participants in the Experimental Group 
(61.9%) had negative positions, that is, the NCS was signifi-
cantly lower when end of therapy (p = 0.002), with a reduced 
variation of one to 23 cigarettes. However, in the Control 
Group, the reduction rate of 33.3% (three subjects) was not 
significant (p = 0.102), ranging from two to 20 cigarettes.
Degree of nicotine dependence
Table 3 shows levels of severity of nicotine depen-
dence during the study period. No significant differences 
were observed between the groups, since there was DND 
reduced in both groups.
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By analyzing the levels of dependence presented in 
Table 4, we found no significant differences between 
groups at baseline, end and follow-up assessments. 
However, we observed the presence of important clini-
cal findings, since the Experimental Group, at baseline 
had 10 participants (47.6%) with very high degree of 
dependence and, at the end of treatment, this index 
decreased for three subjects (14.3%), as well as the 
reduction in the Control Group was seven (77.7%) for 
three subjects (33.3%).
Exhaled carbon monoxide (COex)
In COex evaluation during treatment, we observed in 
Table 5 a difference of six ppm between the groups for the 
association between follow-up and baseline (p = 0.021). 
This means that the Experimental Group reduced about 
3.6 ppm of Coex, while the control group increased the 
level of 2.4 ppm. We highlight all associations in larger re-
duction of COex levels during the sessions for the Experi-
mental Group.
Table 3 – Degree of nicotine dependence (DND) during the 
study, mean difference in the Experimental and Control Group - 
Minas Gerais, 2014
DND vs Grups Mean difference
Standard 
error p-value
5th session 
versus baseline
Experimental -0.6 0.1
0.133
Control -1.1 0.4
7th session 
versus baseline
Experimental -0.9 0.1
0.678
Control -0.7 0.4
End versus 
baseline
Experimental -1.0 0.2
0.704
Control -1.2 0.4
Follow-up 
versus baseline
Experimental -0.9 0.2
0.446
Control -0.5 0.5
Follow-up 
versus End
Experimental 0.1 0.1
0.136
Control 0.6 0.3
Student’s t-test.
Table 4 – Description of the degree of severity of nicotine dependence - Minas Gerais, 2014
Variable
Experimental (n=21) Control (n=9) Total (n=30)
p–value
f % f % f %
Baseline Very low 2 9.5 – – 2 6.7
0.260Low 5 23.8 2 22.2 7 23.3
Medium 4 19.0 – – 4 13.3
High 6 28.6 4 44.4 10 33.3
0.260
Very high 4 19.0 3 33.3 7 23.3
End Very low 7 33.3 3 33.3 10 33.3
0.563
Low 7 33.3 2 22.2 9 30.0
End Medium 4 19.0 1 11.1 5 16.7
0.563High 2 9.5 1 11.1 3 10.0
Very high 1 4.8 2 22.2 3 10.0
Follow–up Very low 6 28.6 3 33.3 9 30.0
0.107
Low 8 38.1 – – 8 26.7
Medium 3 14.3 2 22.2 5 16.7
High 2 9.5 – – 2 6.7
Very high 2 9.5 3 33.3 5 16.7
Teste Mann-Whitney.
Table 5 - Exhaled carbon monoxide (COex) during the study and 
mean difference of the Experimental Group and Control - Minas 
Gerais, 2014
COex vs Groups Mean difference
Standard 
error p-value
5th session 
versus baseline
Experimental -3.5 2.2
0.224
Control -0.4 1.1
7th session 
versus baseline
Experimental -2.7 1.6
0.198
Control 0.8 1.6
End versus 
baseline
Experimental -4.1 1.7
0.172
Control -0.1 1.8
Follow-up 
versus baseline
Experimental -3.6 1.4
0.021*
Control 2.4 1.8
Follow-up 
versus End
Experimental 0.5 0.9
0.246
Control 2.5 1.1
Student’s t-test; * p-value ≤ 0,05.
There were clinical differences at the end of the treat-
ment between groups, since the Experimental Group re-
duced an average of 4.1 ppm of COex, whereas in the Con-
trol Group the mean difference was 0.1 ppm.
Fagerstrom test for nicotine dependence
Three aspects addressed by FTND presented signifi-
cant changes during treatment with auriculotherapy in 
the experimental group. We evidenced by the compari-
son between end and baseline that 38% of participants 
in the Experimental Group did not present difficulties in 
abstaining from smoking in forbidden places, at the end 
of treatment (p = 0.050). Also 23.8% of the participants in 
the Experimental Group reported that they did not smoke 
when bedridden by illness, at the end of the study (p = 
0.025) and 61.9% for the number of cigarettes smoked per 
day was lower at the end of treatment (p = 0.002).
diSCUSSion
This study aimed to assess the contribution of the use 
of auriculotherapy in smoking cessation. We found that the 
use of auriculotherapy for smoking cessation contributed 
to reducing the NCS and COex, indicating the positive effect 
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of this technique with the proposed methodology. Howev-
er, there was no complete cessation of smoking, which may 
be related to study characteristics, such as treatment time, 
material used for auriculotherapy and the protocol chosen.
Some limitations can be pointed for this research, 
such as the small number of subjects, lack of randomiza-
tion and sample calculation. Therefore, further studies 
are needed with larger sample, to know the effect of the 
application of auriculotherapy in smoking cessation. Such 
studies are still scarce, particularly in relation to treatment 
protocols. The available studies(9-10,17) tested various forms 
of treatment with different methodologies, which result-
ed in different results.
In the present study, the application of auriculothera-
py used mustard seeds as they are not invasive and partic-
ipants have higher tolerance(18), however, there is also evi-
dence of a positive result with the use of needles. Study(19) 
that tested the applicability of auriculotherapy comparing 
the use of needles and seeds to assess the reduction of 
stress in nurses showed important contributions of this 
technique in reducing stress. The best results were ob-
tained by the group that used needles, since it was not 
necessary to stimulate ear points(19).
Regarding the pattern of tobacco use in the present 
study, we observed a variation in the reduction of one 
to 23 cigarettes among participants in the Experimen-
tal Group, expressive value, since the mean cigarettes 
smoked at the start of treatment was 18. Thus, even if 
we did not achieved smoking cessation, participants have 
substantially reduced the number of cigarettes smoked.
The finding in terms of reduction in cigarette use, in 
this study, suggests that the technique can bring positive 
benefits to worker health. A prospective cohort study(20), 
conducted with 4,633 male workers who were smokers, 
found that reducing the number of cigarettes smoked per 
day may reduce by 15% the risk of mortality and 23% the 
risk of mortality from cardiovascular problems.
Given the results of this study, as well as the evidence 
found in the literature, one can reflect on the use of auric-
ulotherapy combined with other treatment methods. The 
association of auriculotherapy with other types of inter-
vention of motivational nature may enhance the benefits 
in individuals who are trying to quit smoking.
In this context, the authors also argue that the absence 
of motivational strategies and practical counseling(21) neg-
atively interfere in smoking cessation. Study that evaluat-
ed the effects associated with the application of intensive 
motivational counseling obtained as a result a reduction 
of 89.7% in smoking cessation in the first week of auric-
ulotherapy(22). Study using counseling and motivational 
strategies suggest the need for inclusion and expansion of 
the variables associated to therapeutic treatments(23).
In line with the reduction of NCS, we showed that the 
Experimental Group reduced an average of 4.1 ppm COex. 
This result shows the potential of clinical applicability and 
good correlation between the methods of assessment 
of smoking (behavioral and biological marker). Biological 
methods have great advantage over the others, by the 
excellent accuracy and objectivity. Specifically, measure-
ment of COex is a cost effective method, which allows us 
to offer immediate feedback to the individual, thus it has 
been employed in programs addressing smoking, promot-
ed by government agencies.
The FTND is a widely used instrument in clinical prac-
tice and research(5). This study identified changes in smok-
ing habits, since detected shifts in difficult to abstain from 
smoking in places where it is forbidden to smoke, smoke 
even if ill and the number of cigarettes smoked per day, 
with significant differences to the Experimental Group, re-
inforcing that auriculotherapy can contribute in reducing 
the number of cigarettes smoked.
It is worth noting that smoking is a causal factor of 
various diseases and currently accounts for 30% of all 
cancer deaths, 85% of deaths from COPD (emphysema), 
30% of deaths from cerebrovascular disease and 45% 
of deaths from cardiovascular diseases(24). Therefore, 
the fact that a portion of the study participants have re-
duced smoking when ill, is an important achievement, 
compared to the magnitude of the consequences of 
smoking. Many people smoke because of nicotine de-
pendence and sometimes the consequences of this habit 
is only observed over time.
ConCLUSion
In this study, a pioneer in Brazil on the subject inves-
tigated, the treatment with auriculotherapy helped in re-
ducing the number of cigarettes smoked for 61.9% of par-
ticipants, reducing the difficulty to abstain from smoking 
in places where it is forbidden to smoke for 38% and not 
smoking when ill for 23.8%. However, it does not mean 
that smoking has ceased completely. As quitting smoking 
remains a challenge due to its complex and multifactorial 
factors, involving biological, psychological and behavioral 
aspects.
A strong point of this study refers to the reduction in 
the number of cigarettes smoked, implying increased sur-
vival and improvement in various aspects of quality of life 
of smokers. Therefore, it is suggested that future studies 
consider this contribution associated with other ways of 
treatment, including the assessment of motivational state 
before the start of treatment and promote counseling and 
motivational strategies in order to achieve better results 
in the cessation/withdrawal.
The present study has some limitations. One of them 
is related to sample size, with a small number of partici-
pants. Thus, it is considered timely to conduct studies with 
larger samples and in other healthcare environments, such 
as specialized centers for the treatment of chemical depen-
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dence. Also, another important limitation concerns the as-
sessment of comorbidities, such as the presence of depres-
sion and anxiety, which were not evaluated in this study.
We conclude that the use of the technique of auricu-
lotherapy can bring important contributions as a comple-
mentary therapy in tobacco control.
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